Novavax (NVAX) Reports Q4 Loss, Lags Revenue Estimates

Novavax (NVAX) came out with a quarterly loss of $1.44 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $2.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -193.88%. A quarter ago, it was expected that this vaccine maker would post a loss of $1.82 per share when it actually produced a loss of $1.26, delivering a surprise of 30.77%.Over the last four quarters, the company has surpasse ...